Objective
- To understand the molecular mechanisms of hantavirus replication and to define potential targets for antiviral therapy.
- To determine the extent of genetic variation of known hantaviruses in rodents and humans and to define the distribution of hantavirus infections and diseases in Europe and to isolate novel European hantaviruses.
- To elucidate mechanisms underlying the development of disease. Biological factors for transmission of infection from rodent to man and the possible control of such factors will be investigated.
- To develop reagents for antiviral therapy and immune intervention and to further develop a candidate vaccine now shown to be efficient in an animal model.
Brief descristion:
Hantaviruses are important European pathogens, transmitted to humans from chronically infected rodents. Hantaviruses cause hernorrhagic fevers with renal syndrome and hantavirus-associated pulmonary syndrome and are prime examples of emerging and re-emerging viruses. We wish to understand the molecular mechanisms of hantavirus replication using reverse genetics and studies on hantavirus protein-RNA and protein-protein interactions. This work also aims to define potential targets for antiviral therapy. We plan to to determine the extent of genetic variation of known hantaviruses in rodents and humans and to define the distribution of hantavirus infections and diseases in Europe. We will also continue efforts to isolate novel European hantaviruses. We elucidate mechanisms underlying the development of disease, including definition of the primary site of infection and the nature of the inflammatory host response. We develop reagents for antiviral therapy and immune intervention (synthetic peptides, recombinant gene products) and to further develop a candidate vaccine now shown to be efficient in an animal model. The present project proposal represents a collaborative effort of five units in Finland, Sweden and UK, experienced in hantavirus research. We represent pioneering work (discovery of several hantaviruses) and expertise in molecular genetics and epidemiology peptide technology, immune response, monoclonal antibodies and animal experiments, diagnostics and pathophysiology, and rodent ecology. The units have ongoing collaborations. Rodent and human samples will be/have been obtained also from BosniaHerzegovina, Czech Republic, Estonia, Latvia, Lithuania, Norway, Russia, Slovenia, Switzerland and UK.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules proteins proteomics
- medical and health sciences health sciences public health epidemiology
- medical and health sciences basic medicine physiology pathophysiology
- medical and health sciences basic medicine immunology
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
00014 HELSINKI
Finland
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.